Chinese-made MRNA Vaccine Starts Trial Production

China's CanSino Biologics Inc has entered 'test production phase' for its COVID-19 mRNA booster vaccine, the company said in a post on its social media account.

Related Keywords

China ,Shanghai ,Hong Kong ,Jacqueline Wong ,Casey Hall ,China Cansino Biologics Inc ,Pfizer ,Cansino Biologics Inc ,Covid 19 ,019 Novel Coronavirus ,019 Ncov ,Uhan Coronavirus ,Uman Coronavirus Hku1 ,Uman Coronavirus Oc43 ,Cov Oc43 ,Uman Coronavirus 229e ,Cov 229e ,Corona Virus ,Ovid19 ,Ovel Coronavirus Sars Cov 2 ,Vaccine ,Vaccines ,Social Media ,Covid 19 Omicron Variant ,Ovid 19 Omicronb 1 529 Variant ,Ovid 19b 1 529 Variant ,Ars Cov 2b 1 529 Variant ,